• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Critique of "Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection".

作者信息

Ito Hiroshi

机构信息

Division of Hospital Medicine, University of Tsukuba Hospital, Tsukuba, Japan.

出版信息

Pharmacotherapy. 2020 Sep;40(9):984. doi: 10.1002/phar.2455.

DOI:10.1002/phar.2455
PMID:33112453
Abstract
摘要

相似文献

1
Critique of "Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection".《对“在非暴发性严重艰难梭菌感染的重症患者中，静脉注射甲硝唑联合口服万古霉素治疗的评估”的评论》
Pharmacotherapy. 2020 Sep;40(9):984. doi: 10.1002/phar.2455.
2
Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?静脉注射甲硝唑是否能改善艰难梭菌感染的疗效？
Clin Infect Dis. 2020 Dec 3;71(9):2414-2420. doi: 10.1093/cid/ciz1115.
3
Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection.评价静脉注射甲硝唑联合口服万古霉素治疗非暴发性严重艰难梭菌感染危重症患者的效果。
Pharmacotherapy. 2020 May;40(5):398-407. doi: 10.1002/phar.2393. Epub 2020 Apr 21.
4
Review of high dose vancomycin in the treatment of infection.高剂量万古霉素治疗感染的综述。
Infect Dis (Lond). 2020 Nov-Dec;52(12):847-857. doi: 10.1080/23744235.2020.1800080. Epub 2020 Aug 3.
5
Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci.口服万古霉素治疗艰难梭菌感染与万古霉素耐药肠球菌风险。
Clin Infect Dis. 2020 Jul 27;71(3):645-651. doi: 10.1093/cid/ciz871.
6
Intravenous metronidazole for fulminant Clostridioides difficile infection.静脉注射甲硝唑治疗暴发性艰难梭菌感染。
Clin Microbiol Infect. 2023 May;29(5):656-657. doi: 10.1016/j.cmi.2023.01.026. Epub 2023 Feb 3.
7
Analysis of the impact of secondary prophylaxis on recurrence in critically ill adults.二级预防对重症成年患者复发影响的分析
SAGE Open Med. 2020 Jun 12;8:2050312120930898. doi: 10.1177/2050312120930898. eCollection 2020.
8
Initial therapy affects duration of diarrhoea in critically ill patients with Clostridioides difficile infection (CDI).初始治疗会影响艰难梭菌感染（CDI）危重症患者腹泻的持续时间。
Crit Care. 2019 Dec 9;23(1):399. doi: 10.1186/s13054-019-2648-6.
9
Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials.口服万古霉素与甲硝唑治疗艰难梭菌感染：随机对照试验的荟萃分析
J Infect Chemother. 2018 Nov;24(11):907-914. doi: 10.1016/j.jiac.2018.08.003. Epub 2018 Aug 29.
10
The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.静脉注射甲硝唑联合口服万古霉素可改善艰难梭菌感染的危重症患者的死亡率。
Clin Infect Dis. 2015 Sep 15;61(6):934-41. doi: 10.1093/cid/civ409. Epub 2015 May 29.